申请人:Allergan, Inc.
公开号:US20190119304A1
公开(公告)日:2019-04-25
Described herein is a compound having a chemical structure of Formula A:
wherein m, p, q, W, Z, Y, X
1
, X
2
, R
1
, R
2
, R
3
and R
4
are as defined herein. A diastereo-selective reduction of the compound comprising contacting the compound of Formula A with a reducing agent in an aprotic polar or non-polar solvent is also described.
本文描述了一种具有化学结构为A的化合物:
其中m、p、q、W、Z、Y、X1、X2、R1、R2、R3和R4如本文所定义。还描述了一种选择性差向异构体还原该化合物的方法,包括将化合物A的化合物与还原剂在无极性或非极性溶剂中接触。